DashboardAll companies
Run this on your own research
Healthcare · Medical Devices

Steris plc

STENYSE$232.15−$0.07 (−0.03%)Market closed

Price Chart

Daily

Key facts

Market Cap
$22.66B
P/E
29.1x
P/B
3.17x
ROE
11.3%

Steris plc

Healthcare · Medical Devices · FY 2026

Steris plc is a multinational company specializing in medical equipment with a strong focus on infection prevention and sterilization solutions. The company offers a comprehensive range of products and services designed to support patient care, including cleaning and sterilization chemicals, accessories for gastrointestinal procedures, washers, sterilizers, surgical tables, and operating room equipment. Steris plc also provides specialized healthcare services such as equipment installation, maintenance, instrument and endoscope repair, laboratory testing, and consulting for process improvement in clinical settings. Its operations span several business segments, notably Healthcare Products, Life Sciences, and Applied Sterilization Technologies, serving acute care hospitals, pharmaceutical manufacturers, and life science organizations. With a significant market presence in the United States and growing international reach, Steris plc plays a critical role in advancing safety standards and efficiency for healthcare providers globally, positioning itself as one of the leading suppliers in the infection control and procedural services sector.

CEO
Mr. Daniel A. Carestio
Employees
17,787
Website
steris.com

Company Statistics

Valuation

P/E
29.1x
P/B
3.17x
P/S
3.84x
EV/EBITDA
15.3x
P/FCF
23.4x

Margins

Gross
44.2%
EBITDA
26.9%
Operating
18.6%
Pre-Tax
17.6%
Net
13.2%

Returns

ROA
7.5%
ROE
11.3%
ROIC
10.6%

Growth (CAGR)

Rev 3Yr
9.4%
Rev 5Yr
13.8%
Op Inc 3Yr
11.8%
Net Inc 3Yr
95.0%

Financial Health

Cash & Cash Equivalents
$439.6M
Net Debt
$3.10B
Debt/Equity
49.2%
Interest Cov
—

Profile

Revenue
$5.94B
Shares Out
—
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Steris plc (STE) Stock Forecast 2026 $232.15 — Price, Financials & Analyst Targets | AlphaLenz